Source: Health Canada shortage reports · Updated Aug 7, 2026
Capecitabine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
Products affected
0 / 14
Reports on file
52
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
CAPECITABINE
500MG · TABLET · JAMP PHARMA CORPORATION
DIN 02519887 · ended Aug 6, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Jan 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 18, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 16, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Nov 5, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
150MG · TABLET · SANIS HEALTH INC
DIN 02514982 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
500MG · TABLET · SANIS HEALTH INC
DIN 02514990 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jul 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Apr 16, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Feb 17, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
150MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421917 · ended Dec 16, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 52 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Capecitabine. Health Canada has 52 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Capecitabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Aug 7, 2026
Shortage resolved
Jul 29, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 31, 2026
Common questions
What is Capecitabine used for?
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
When will Capecitabine be back in stock in Canada?
Capecitabine has no active shortage; supply is normal per Health Canada reports.
Why is Capecitabine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.